Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 14/20 | 1.00 |
| ▸ | PGR | P06401 | 5/20 | 0.76 |
| ▸ | AR | P10275 | 5/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.76 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.76 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.76 |
| ▸ | MAPT | P10636 | 1/20 | 0.76 |
| ▸ | RAB9A | P51151 | 1/20 | 0.76 |
| ▸ | MEN1 | O00255 | 1/20 | 0.75 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.75 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.73 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.73 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.73 |
| ▸ | CNR1 | P21554 | 1/20 | 0.66 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluticasone SCHEMBL65401 | 1.00 | NR3C1 (1.00) | NR3C1PGRARCYP3A4HIF1A | |
| Fluticasone SCHEMBL14135286 | 1.00 | NR3C1 (1.00) | NR3C1PGRARCYP3A4HIF1A | |
| Fluticasone SCHEMBL2231799 | 1.00 | NR3C1 (1.00) | NR3C1PGRARCYP3A4HIF1A | |
| Fluticasone SCHEMBL28888601 | 0.99 | NR3C1 (0.98) | NR3C1PGRARCYP3A4HIF1A | |
| Fluticasone SCHEMBL28821706 | 0.99 | NR3C1 (0.98) | NR3C1PGRARCYP3A4HIF1A | |
| Fluticasone SCHEMBL28935320 | 0.98 | NR3C1 (0.97) | NR3C1PGRARCYP3A4HIF1A | |
| Fluticasone SCHEMBL27674669 | 0.97 | NR3C1 (0.95) | NR3C1PGRARCYP3A4HIF1A | |
| Fluticasone SCHEMBL896670 | 0.97 | NR3C1 (0.93) | NR3C1PGRARCYP3A4HIF1A | |
| Fluticasone SCHEMBL29113054 | 0.96 | NR3C1 (0.92) | NR3C1PGRARCYP3A4HIF1A | |
| Fluticasone SCHEMBL3365958 | 0.95 | NR3C1 (0.91) | NR3C1PGRARCYP3A4HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 40234 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6423298-B1 | — | — | None | — | — | US | claimed |
| EP-4747263-A1 | LIPID NANOPARTICLES AND USES THEREOF | University of Connecticut (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260137656-A1 | METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS | SPARROW PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | claimed |
| US-20260137657-A1 | METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS | SPARROW PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| US-20260130899-A1 | METHOD OF TREATMENT FOR PREVENTION OF GLUCOCORTICOID TOXICITY AND/OR ENHANCEMENT OF MUSCLE REGENERATION VIA NEUTROPHIL ELASTASE INHIBITION | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2026-05-14 | — | — | US | claimed |
| US-20260125650-A1 | METHODS AND COMPOSITIONS FOR GENERATING HEPATOCYTES | TRAILHEAD BIOSYSTEMS INC (US) | 2026-05-07 | — | — | US | claimed |
| US-20260125686-A1 | COMPOSITIONS AND METHODS FOR MODULATION OF CFTR | CYSTIC FIBROSIS FOUND (US) | 2026-05-07 | — | — | US | claimed |
| EP-4736841-A1 | A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT | IQ medical GmbH (DE) | 2026-05-06 | — | — | EP | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-0577760-A1 | SEQUENTIAL DOSING OF ANTIFUNGAL AND ANTIINFLAMMATORY COMPOSITIONS | GLAXO WELLCOME INC. (US) | 1994-01-12 | — | — | EP | claimed |
| EP-0278174-B1 | USE OF FLUTICASONE PROPIONATE IN THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF BOWEL DISEASES | GLAXO GROUP LIMITED (GB) | 1993-03-10 | — | — | EP | claimed |
| US-5174475-A | Dispensing a first component followed by second without adjustment | GLAXO INC. (US) | 1992-12-29 | — | — | US | claimed |
| WO-1992018133-A1 | METHOD OF TREATMENT USING STEROID MOUTHWASH | EISEN DRORE (US) | 1992-10-29 | — | — | WO | claimed |
| WO-1992017183-A1 | SEQUENTIAL DOSING OF ANTIFUNGAL AND ANTIINFLAMMATORY COMPOSITIONS | GLAXO INC. (US) | 1992-10-15 | — | — | WO | claimed |
| EP-0470154-A1 | DRY POWDER INHALATION DEVICE. | RIKER LABORATORIES INC (US) | 1992-02-12 | — | — | EP | claimed |
| US-5049389-A | Non-phospholipd lipid, delivery by inhalation | LIPOSOME TECHNOLOGY, INC. (US) | 1991-09-17 | — | — | US | claimed |
| WO-1990013328-A1 | DRY POWDER INHALATION DEVICE | RIKER LABORATORIES, INC. (US) | 1990-11-15 | — | — | WO | claimed |
| WO-1990013327-A1 | DRY POWDER INHALATION DEVICE | RIKER LABORATORIES, INC. (US) | 1990-11-15 | — | — | WO | claimed |
| WO-1990006775-A1 | A NOVEL NONPHOSPHOLIPID LIPOSOME COMPOSITION FOR SUSTAINED RELEASE OF DRUGS | LIPOSOME TECHNOLOGY, INC. (US) | 1990-06-28 | — | — | WO | claimed |